Project Iovance C-144-01

Basic data

Title:
Iovance C-144-01
Duration:
18/05/2018 to 17/05/2024
Abstract / short description:
A Phase 2, Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma”, Protocol Number: C-144-01

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

San Carlos, Kalifornien, United States of America
Help

will be deleted permanently. This cannot be undone.